ARESTOCAINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Arestocaine Hydrochloride patents expire, and when can generic versions of Arestocaine Hydrochloride launch?
Arestocaine Hydrochloride is a drug marketed by Solvay and is included in two NDAs.
The generic ingredient in ARESTOCAINE HYDROCHLORIDE is levonordefrin; mepivacaine hydrochloride. There are two drug master file entries for this compound. Additional details are available on the levonordefrin; mepivacaine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ARESTOCAINE HYDROCHLORIDE?
- What are the global sales for ARESTOCAINE HYDROCHLORIDE?
- What is Average Wholesale Price for ARESTOCAINE HYDROCHLORIDE?
Summary for ARESTOCAINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 113 |
| Patent Applications: | 1,009 |
| DailyMed Link: | ARESTOCAINE HYDROCHLORIDE at DailyMed |
US Patents and Regulatory Information for ARESTOCAINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solvay | ARESTOCAINE HYDROCHLORIDE | mepivacaine hydrochloride | INJECTABLE;INJECTION | 084777-002 | Apr 18, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Solvay | ARESTOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN | levonordefrin; mepivacaine hydrochloride | INJECTABLE;INJECTION | 085010-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
